World's Best Scientists 2026 revealed!
Jean-Paul Soulillou

Jean-Paul Soulillou

D-Index & Metrics

Immunology

D-Index
87
Citations
26592
World Ranking
1213
National Ranking
44

Medicine

D-Index
87
Citations
26618
World Ranking
13693
National Ranking
441

Jean-Paul Soulillou publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jean-Paul Soulillou sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 633 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jean-Paul Soulillou D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Paul Soulillou sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 87 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jean-Paul Soulillou is affiliated with the University of Nantes in France and focuses primarily on medical research with an emphasis on surgery and immunology. Their research integrates multiple subfields including cardiology and cardiovascular medicine, epidemiology, and genetics, contributing to a diverse spectrum of medical knowledge.

Their recent published works cover a range of topics within immunology and transplantation medicine. Notable publications include the 2022 study titled The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration published in Nature Medicine. Other significant articles are Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome (2020, Frontiers in Immunology), Gut bacteria Akkermansia elicit a specific IgG response in CSF of patients with MS (2020, Neurology Neuroimmunology & Neuroinflammation), High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 (2021, European Journal of Immunology), and Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trial (2020, American Journal of Transplantation).

The primary topics addressed in Jean-Paul Soulillou's research cover:

  • Xenotransplantation and immune response
  • Renal Transplantation Outcomes and Treatments
  • Cardiac Valve Diseases and Treatments
  • Monoclonal and Polyclonal Antibodies Research
  • T-cell and B-cell Immunology
  • Diabetes and associated disorders
  • Infective Endocarditis Diagnosis and Management

Jean-Paul Soulillou frequently publishes in venues such as Frontiers in Immunology, bioRxiv (Cold Spring Harbor Laboratory), Clinical Immunology, Nature Medicine, and Neurology Neuroimmunology & Neuroinflammation. Their collaborations have included multiple co-authors, notably:

  • Emanuele Cozzi
  • Jean-Marie Bach
  • Cesare Galli
  • Sophie Brouard
  • Laureline Berthelot

Jean-Paul Soulillou's work in medicine displays substantial contributions across surgery-related studies and immunological research, particularly in transplantation and antibody responses. Their interdisciplinary focus incorporates epidemiological frameworks and genetic aspects of diseases, supporting a broad approach to complex medical challenges.

Best Publications

  • Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

    Björn Nashan;Richard Moore;Peter Amlot;Albrecht-Georg Schmidt

  • Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

    Jacques Dantal;Maryvonne Hourmant;Diego Cantarovich;Magali Giral

  • Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

    Pervinder Sagoo;Esperanza Perucha;Birgit Sawitzki;Stefan Tomiuk

  • A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells.

    Dominique Chabannes;Marcelo Hill;Emmanuel Merieau;Julien Rossignol

  • Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome

    Jacques Dantal;Edith Bigot;Willy Bogers;Angelo Testa

  • Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation.

    Agnes Debout;Yohann Foucher;Katy Trébern-Launay;Christophe Legendre;Christophe Legendre

  • Multiparameter immune profiling of operational tolerance in liver transplantation.

    M. Martínez-Llordella;I Puig-Pey;G. Orlando;M. Ramoni

  • Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance

    Sophie Brouard;Elaine Mansfield;Christophe Braud;Li Li

  • Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation

    Maryvonne Hourmant;Anne Cesbron-Gautier;Paul I. Terasaki;Kazuo Mizutani

  • Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts

    J P Soulillou;D Cantarovich;B Le Mauff;M Giral

  • Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.

    Stéphanie Louis;Cécile Braudeau;Magali Giral;Alexandre Dupont

  • Immunosuppressive drugs and the risk of cancer after organ transplantation.

    Jacques Dantal;Jean-Paul Soulillou

  • Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys

    Magali Giral-Classe;Maryvonne Hourmant;Diego Cantarovich;Jacques Dantal

  • Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype

    Annaick Pallier;Sophie Hillion;Richard Danger;Magali Giral

  • Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial

    M Behrend;J Grinyo;Y Vanrenterghem;J Rodicio

  • Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.

    Stéphanie Coupel;Anne Moreau;Mohamed Hamidou;Vaclav Horejsi

  • Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.

    M. Giral;Y. Foucher;A. Dufay;J. P. D. Van Huyen

  • A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.

    R Josien;P Douillard;C Guillot;M Müschen

  • Clinical operational tolerance after kidney transplantation.

    G. Roussey-Kesler;M. Giral;A. Moreau;J.-F. Subra

  • Five-Year Safety and Efficacy of Belatacept in Renal Transplantation

    Flavio Vincenti;Gilles Blancho;Antoine Durrbach;Peter Friend

  • Acute graft pyelonephritis and long-term kidney allograft outcome.

    Magali Giral;Giovani Pascuariello;Georges Karam;Maryvonne Hourmant

Frequent Co-Authors

Sophie Brouard
Sophie Brouard University of Nantes
Maria-Cristina Cuturi
Maria-Cristina Cuturi University of Nantes
Ignacio Anegon
Ignacio Anegon University of Nantes
Régis Josien
Régis Josien Grenoble Alpes University
Yannick Jacques
Yannick Jacques University of Nantes
Lionel Rostaing
Lionel Rostaing Grenoble Alpes University
Cesare Galli
Cesare Galli University of Bologna
Hai Yu
Hai Yu University of California, Davis
Xi Chen
Xi Chen University of California, Davis
Henri Kreis
Henri Kreis Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with advanced healthcare roles, especially within nursing specialties such as psychiatric and acute care nurse practitioners. For those interested in psychiatric care, exploring the best pmhnp programs can provide strong clinical training and improve job placement opportunities.

Cost is also a significant factor when choosing a program. Many students seek out more affordable options without compromising quality, making the research into the cheapest psychiatric nurse practitioner programs highly valuable for budget-conscious learners.

Career progression often involves transitioning between specialties. For example, nurses interested in expanding their scope can consider the path on how to transition from fnp to acnp, enabling a shift from family practice to acute care settings, which may align with immunological expertise in critical care environments.

Understanding the financial outlook is also crucial. Salaries for advanced degrees like the Doctor of Nursing Practice (DNP) vary by location; consulting data on dnp salary by state helps candidates make informed decisions about where to study and work for optimal earnings.

Best Scientists Citing Jean-Paul Soulillou

Trending Scientists

Recently Published Articles